HMD

0.00%

1.8¢ heramed limited

For some industry relevant funding context: Maternity care...

First 32 Last

Share
Profile

Follow
Backspacer

257 Posts.

94

05/07/23

12:10

Post #: 68630758
Share

Originally posted by Kirpa: ↑

It's obvious this is being "ticked up" for a capital raising and they're trying to limit the dilution. Fair enough. Being ASX listed as a tech start up is problematic. The pool of investors is tiny and very unsophisticated in tech and that includes family offices and funds. The money just gets churned from one deal to the next. So here we are ignored and about to get diluted again.

A French tech start up called Mistral AI just raised US$113M "seed' at a US$260M valuation. That's not even a Series A. Here we are at $20M with a supposed world class health platform with a massive addressable market and all people are talking about is how do we get to cash flow break even for goodness sake. It's not an industrial play. It's tech and as Elon Musk once said in an interview when questioned as to when Tesla would be cash flow positive, if you're high tech and you're main goal is cash flow break even you're in the wrong game. HMD is in a land grab. The goal here should be to nail 100,000 licences by 2025/26 and if they can't do that then forget about it.

https://techcrunch.com/2023/06/13/frances-mistral-ai-blows-in-with-a-113m-seed-round-at-a-260m-valuation-to-take-on-openai/?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce_referrer_sig=AQAAAL4b_ZPUv1OcS4ZHq3NmdQkGL0rc5JZAX04JqWUAycOC-1bhOyR2ICLa78fiQ4-RH9wVAB0GrVFw9VGsTHmgdU93bIH_xqMbxd4OyI6Quz206Rej9qp9Eo8hzN6rI3xw-HfAnR1uXH75f6CtwhKBVTv_dL8LVwX7yKusGLt8OyFy

Expand

For some industry relevant funding context: Maternity care platform Pomelo Care recently received $33 million in series A by Andreessen Horowitz.
https://www.mobihealthnews.com/news/maternity-care-platform-pomelo-care-raises-33m-and-more-digital-health-fundings
https://a16z.com/2023/06/08/investing-in-pomelo-care/

still money flowing. Lets go HMD, 100,000 licences by 25/26...

HMD Price at posting: 8.5¢ Sentiment: Hold Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

NAM

ACCC seeks Olam divestments before it can buy Namoi Cotton

The winners & losers on market if negative gearing were gone

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

ESR

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

The market's shrugged at China's stimulus measures all year. Why is this one different?

STK

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

DEG

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

KAL

KalGold rolls out detailed aeromagnetic survey across Pinjin project

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

There are more pages in this discussion • 13 more messages in this thread...

First 32 Last

Add HMD (ASX) to my watchlist

(20min delay)
Last 1.8¢		Change 0.000(0.00%)		Mkt cap ! $11.39M

Open	High	Low	Value	Volume
1.8¢	1.8¢	1.8¢	$900	50K

Buyers (Bids)

No.	Vol.	Price($)
4	1645009	1.8¢

Sellers (Offers)

Price($)	Vol.	No.
2.3¢	200000	1

View Market Depth

No.	Vol.	Price($)
4	1645009	0.018
1	998971	0.016
2	1042548	0.015
1	200000	0.014
1	500000	0.013

Price($)	Vol.	No.
0.023	200000	1
0.024	200000	1
0.025	72222	1
0.026	156429	1
0.027	150000	1

Last trade - 12.49pm 27/09/2024 (20 minute delay)

HMD (ASX) Chart

For some industry relevant funding context: Maternity care...

ACCC seeks Olam divestments before it can buy Namoi Cotton

The winners & losers on market if negative gearing were gone

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

The market's shrugged at China's stimulus measures all year. Why is this one different?

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

KalGold rolls out detailed aeromagnetic survey across Pinjin project

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

For some industry relevant funding context: Maternity care...

Top Stories

ACCC seeks Olam divestments before it can buy Namoi Cotton

The winners & losers on market if negative gearing were gone

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

The market's shrugged at China's stimulus measures all year. Why is this one different?

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

KalGold rolls out detailed aeromagnetic survey across Pinjin project

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News